TruthArchive.ai - Related Video Feed

Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1,500 a month, and most have taken money from Novo Nordisk, the drug's manufacturer. There is a push to recommend Ozempic for Americans as young as six for obesity, a condition claimed to be preventable. It is claimed that if 74% of Americans took Ozempic, the cost would be $3 trillion a year. Ozempic has made Novo Nordisk the biggest company in Europe, yet the Danish government recommends diet and exercise instead. It is claimed that for half the price of Ozempic, every American could receive regeneratively raised organic food and gym memberships. It is claimed that members of Congress are doing the bidding of Novo Nordisk instead of standing up for American farmers and children because Novo Nordisk is one of the largest funders of medical research.

A businessman told the speaker that the same fat shot drug cost him $88 in London, but $1,300 in New York. He was stunned that the identical pill, made in the same plant by the same company, had such different prices. The speaker discussed this with drug company representatives. They argued for about half an hour, but ultimately the representative admitted there was no justification for the price difference.

The speaker claims the United States spends $1,126 per capita on drugs, while Britain spends about $240, approximately one-fifth of the U.S. figure, a trend seen across Europe. The speaker says drug companies claim America must pay for pharmaceutical innovation. President Trump is quoted as saying European partners need to increase their drug payments to cover their share of innovation, asserting the U.S. should no longer subsidize it. The speaker concludes that if Europeans raised drug prices by 20%, the resulting $10 trillion could be spent on innovation, improving global health.

Speaker contrasts health care in the US and Italy. They state that 'doctors in The US will prescribe antibiotics at any chance they can,' while noting that their boyfriend in Italy was sick and 'he went to his doctor, and his doctor told him to get rest and drink some milk before bed.' They ask, 'I'm sorry, but where is that information in The US?' and describe the difference as 'crazy to me the difference that we see between health care in America versus health care in Italy,' adding that this is 'one tiny example of how the system works in America versus Italy.' The remarks illustrate a perceived disparity in how health care systems operate across the two countries.

The speaker discusses peptides and their rise in popularity on social media, describing them as big pharma products. They claim peptides are essentially the same as big pharma vitamins, just in injectable form, and assert that people are now supporting the same pharmaceutical companies by using peptides rather than taking vaccines. The speaker expresses astonishment that, after 2020, people would inject things into their bodies without knowing what they are putting in, yet peptide injections have become a trending topic across the Internet and social media. They extend the critique to other substances, stating that methylane blue, ivermectin, and nicotine are also part of the same pattern: if something is trendy on social media, it is backed by big pharma. The speaker asserts that this is what is happening with peptides and that big pharma maintains powerful marketing to influence public perception. They claim that big pharma gets people to believe in certain products and to ignore other concerns, such as “cell phone towers out in front of their house,” while encouraging them to jump on the bandwagon of other products to put into their body. The speaker argues that peptides represent a broader phenomenon where trendy health products are promoted by big pharma, similar to the way vaccines were promoted in 2020. They state that after 2020, one would think people would avoid injecting anything into their body because they don’t know what they are putting into it, yet the trend continues with peptides and related products. The overall assertion is that big pharma has strong marketing that convinces people to adopt various products and to overlook potential concerns, shaping consumer behavior through trends on social media. The speaker notes that the peptide trend is part of this larger pattern, alongside other substances like methylane blue, ivermectin, and nicotine, all of which are implied to be backed by big pharma when they gain online popularity.

Novo Nordisk has faced accusations of shady sales tactics, including spending heavily on doctors, and has encountered regulatory issues in multiple countries. The company, along with other drug makers, has been criticized for high insulin prices. While insulin profits have decreased, weight loss drugs offer astronomical profit potential, which Novo Nordisk is already capitalizing on. The company's valuation once exceeded Denmark's entire GDP. Some individuals, distrustful of big pharma or lacking access to these drugs, are seeking alternatives.

Over 100 members of Congress are backing a bill to fund Ozempic through Medicare at $1,500 monthly, many having received funds from Novo Nordisk, its European manufacturer. Once Medicare approves it, Medicaid follows. There's a push to prescribe Ozempic to kids as young as six for obesity, a largely preventable condition. With 74% of Americans obese, covering everyone's Ozempic would cost $3 trillion annually. Ozempic has made Novo Nordisk Europe's largest company, yet Denmark recommends diet and exercise instead. The company's value relies heavily on projected Ozempic sales in the US. For half the cost, we could provide organic food and gym memberships for every obese American. Why are politicians siding with a Danish company over American farmers and kids? Because Novo Nordisk heavily funds medical research, influencing media, politicians, and medical schools.

I'm in a store in Sweden, where food regulations are strict. I found a section with American products, including Airheads. On the back of the packaging, there are warning labels indicating that it contains a substance that can negatively affect a child's behavior and concentration. This highlights the differences in food labeling between the U.S. and Europe.

Over 100 members of Congress support a bill to fund Ozempic through Medicare at $1,500 a month, despite many having received funding from its manufacturer, Novo Nordisk. This drug, aimed at treating obesity—a largely preventable condition—could cost the U.S. $3 trillion annually if prescribed widely, as 74% of Americans are obese. While Novo Nordisk thrives, the Danish government promotes diet and exercise instead. For half the cost of Ozempic, we could provide organic food and gym memberships for every obese American. The influence of Novo Nordisk extends to medical research funding, leading to complicity from media, politicians, and medical schools.

Speaker 0 argues that history will view this presidency as probably the most reckless and corrupt in the history of the United States, and expresses fear that without change the country and the world risk major harm, including the possibility of World War III. They say, regardless of views on global leadership, that being on top “what good is it … if you've created an absolute hellscape?” They emphasize the need for the course to change and suggest the future of the United States as a cohesive country and the world is currently in question because of the administration’s behavior. Speaker 1 agrees that America used to hold the moral high ground—defending human rights, free speech, and free trade—but asserts that none of those things are true any longer. They claim America is “the terror regime of the world,” describing it as pillaging, stealing, bombing, assassinating, running color revolutions, lying, and doing everything possible to destroy others to keep America as the last nation standing on its pile of soon to be worthless debt. They state this is not a moral position from which to lead any civilization. Speaker 0 contends that America has the tools to be all those values, citing a great constitutional republican system, the federation of states, resources, and human capital. They note a problem, however: a “giant pile of worthless fiat paper,” with the bill coming due and the tantrums of an empire, referencing warnings by people like Gerald Celente and Alex Jones about a fiat bubble rupture. They say the question is where the country wants to be in the world, criticizing a lack of imagination among the “great and the good in America” about a compelling future. Speaker 1 adds a new issue: 31 million Americans are injecting themselves with GLP-1 drugs, which they say cause a 100% increase in risk of psychiatric disorders and suicidal ideation, especially among women, with the most use among 50–65-year-olds. They claim Trump is working to make these drugs more affordable so that more people can take them, potentially leading to half of US adults using a drug based on venom peptides of the Gila monster, a paralyzing agent, risking madness. They compare this to lead poisoning and reference Ozempic as one of these drugs. Speaker 0 asks, “What’s it called? Ozempic? Is that a GOP one?” Speaker 1 confirms “Ozempic,” and notes that the drugs are used for vanity to look healthy, not because people are actually healthy. They reiterate the core issue: what goes into bodies and the environment in which people live, stressing that there is an opportunity today to correct and improve the situation, and that many are taking that opportunity.

Pharmaceutical companies claimed research and development costs had to be borne by America alone, which effectively meant American patients were subsidizing socialist healthcare systems in places like Germany and the European Union. The speaker believes the European Union is nastier than China and has treated the U.S. unfairly. However, the speaker asserts that the U.S. now holds all the cards and expects the European Union to concede.

Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1,500 monthly, with most having received money from Novo Nordisk, its manufacturer. Approval for Medicare would extend to Medicaid, with potential recommendations for Americans as young as six for obesity, a condition claimed to be preventable and recently rare. With 74% of Americans obese, the total cost of Ozempic prescriptions could reach $3 trillion annually. Ozempic has made Novo Nordisk the biggest company in Europe, yet the Danish government recommends diet and exercise instead. The company's value relies on projected Ozempic sales in America. For half the cost of Ozempic, every American could receive regeneratively raised organic food and obese Americans could receive gym memberships. The speaker questions why Congress is supporting Novo Nordisk over American farmers and children, suggesting Novo Nordisk's funding of medical research influences media, politicians, and medical schools.

Over 100 members of Congress support a bill to fund Ozempic through Medicare at $1,500 a month, despite many having received funding from its manufacturer, Novo Nordisk. Once approved for Medicare, the drug will likely extend to Medicaid, with recommendations for use in children as young as 6 for obesity, a largely preventable condition. With 74% of Americans classified as obese, the potential annual cost for Ozempic prescriptions could reach $3 trillion. While Novo Nordisk thrives on these projections, the Danish government advocates for dietary changes and exercise instead. For the cost of Ozempic, we could provide organic food and gym memberships for every obese American. The influence of Novo Nordisk in medical research funding raises concerns about Congress prioritizing corporate interests over American health and agriculture.

America's food is banned in 30 countries and is allegedly killing people. Lay's potato chips, for example, have different ingredients in America versus Europe. Over 10,000 food chemicals are allowed in the American food system that are not allowed in other countries. This makes it easier for food companies and gives products longer shelf life due to the chemicals. When people lobby for healthier food choices, the food industry lobbies against it with millions of dollars.

A businessman told the speaker that the same fat shot drug cost him $88 in London but $1,300 in New York. The drugs were identical, made in the same plant by the same company. The speaker discussed this with a representative from the drug companies, who admitted there was no justification for the price difference.

Only two countries worldwide allow pharmaceutical TV ads, including the U.S., where over a billion dollars monthly is spent. These ads convey that Americans frequently experience bowel and bladder issues, active seniors enjoy tennis and sex, and pills can solve any problem, even pill overuse. The speaker questions the need to suggest medications to doctors and highlights the growth of ketamine clinics in America. Western medicine, it's argued, treats respectable drugs differently from street drugs, despite similarities. Oxycodone is heroin, Adderall is meth, and Ritalin is cocaine for kids. Ketamine, once an illegal club drug, was FDA-approved as an anesthetic. The speaker suggests the first drug one uses is the gateway drug, be it beer, pot, or pharmaceuticals prescribed to children. Resisting profitable but harmful substances requires individual effort.

Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1500 a month, and most have taken money from Novo Nordisk, the drug's manufacturer. Once approved for Medicare, it goes to Medicaid, and there's a push to recommend Ozempic for Americans as young as 6 for obesity, a condition claimed to be preventable and recently rare. With 74% of Americans obese, the cost of Ozempic prescriptions for all of them would be $3 trillion a year. Novo Nordisk's value is based on projected Ozempic sales to Americans, yet the Danish government recommends diet and exercise instead. For half the price of Ozempic, every American could receive regeneratively raised organic food and gym memberships. Congress is allegedly doing the bidding of Novo Nordisk instead of supporting American farmers and children because Novo Nordisk heavily funds medical research, the media, politicians, and medical schools.

Over a hundred members of Congress are backing a bill to fund Ozempic through Medicare at $1,500 monthly, many having received funds from Novo Nordisk, its manufacturer. Once Medicare approves, Medicaid follows. There's a push to prescribe Ozempic for obesity in Americans as young as six, a condition largely preventable. With 74% of Americans obese, covering Ozempic prescriptions would cost $3 trillion annually. Novo Nordisk's value relies heavily on projected Ozempic sales in the US, yet Denmark, their home country, favors diet and exercise over the drug. For half the cost of Ozempic, we could provide regeneratively raised organic food to every American, three times a day, and gym memberships for every obese American. Why is Congress prioritizing this company over American well-being? I've dedicated my life to solving the childhood chronic disease crisis, and I see an opportunity for bipartisan change to improve American health, our economy, and our nation's spirit.

The speaker states that the U.S. will tariff pharmaceuticals. They believe this will cause pharmaceutical companies to move back to the U.S. because the U.S. is the biggest market. The speaker asserts that the U.S.'s advantage is being the biggest market. They say a major tariff on pharmaceuticals will be announced shortly. The speaker believes that upon hearing this, pharmaceutical companies will leave China and other places because most of their product is sold in the U.S.

Ozempic has rapidly become a cultural phenomenon, with one in eight US adults having tried GLP-1 drugs. The company producing Ozempic is now valued higher than Coca-Cola and McDonald's combined. Online discussions mention side effects like Ozempic face, hair loss, and severe stomach problems, alongside reports suggesting potential benefits for fertility, Alzheimer's, and even shopping addiction. The speaker questions the complete truth about GLP-1 drugs and weight loss, and has spent months researching and attempting to obtain GLP-1 medication.

A common asthma drug costs almost $500 in America, but less than $40 in The United Kingdom. The speaker highlights the significant price difference, noting one person paid a small amount for the same shot in the UK. The weight loss drug Ozempic costs 10 times more in The United States than in the rest of the developed world, according to the speaker, who questions the reason for this disparity.

The speaker addresses misinformation circulating on social media regarding a certain medication. A recurring claim is that these drugs are new, not well-studied, and not well-understood. Another speaker specifies that there are no studies on what the medication does to a body without diabetes, and no research on a person not diagnosed with type two diabetes. The first speaker refutes the claim that they are untested or not understood, stating that they have been studied a lot for both safety and efficacy for diabetes.

Discussion on why Coca-Cola in the UK and Coca-Cola Echio Mexico are sweetened with cane sugar, while Coke in the USA uses high fructose corn syrup. 'high fructose corn syrup is sweeter than cane sugar, cheaper than cane sugar and more addictive than cane sugar, meaning more profits for the brand and most likely more type two diabetes for you and me.' 'Ours is sweeter. Wow. It has like a cloying sweetness. I prefer the British.' 'I'll take a spot of British Coca Cola any day, which means I'll never have it again.' 'But there's a difference between our Coke versus their. Why do they do it? Because it's all about money.' 'If you want to see the difference between UK Skittles versus ours, let me know.'

A common asthma drug costs almost $500 in America, but less than $40 in The United Kingdom. The speaker stated that an individual in the UK paid a small amount for their shot, contrasting sharply with the $500 cost in the US. The weight loss drug Ozempic costs 10 times more in The United States than in the rest of the developed world. The speaker questions the reason for this disparity.

The average 65-year-old in the US takes about seven drugs. 95% of people on the USDA nutrition guidelines had conflicts of interest with food companies, influencing school lunches, where the USDA serves 3 billion meals yearly. Kraft Heinz is brokering deals to put Lunchables in schools, a top growth area. Novo Nordisk, the Ozempic manufacturer, is now Europe's most valuable company, with almost all revenue from the US due to a broken system. 30% of Americans with insurance coverage stop using Ozempic within three months, despite it being touted as a lifetime drug. Lawsuits are emerging regarding gastrointestinal issues and stomach paralysis, which may persist after discontinuing the drug. The EU is probing suicidal ideation linked to Ozempic. The American Academy of Pediatrics recommends Ozempic as a first-line defense for teens based on a 68-week study. Pharma is the largest TV news ad spender, and Novo Nordisk is a major funder of obesity research, medical groups, and civil rights groups, including paying the NAACP, who claims that not supporting Ozempic is racist. Analyst reports assume increased obesity rates, and loans for obesity treatment centers project growth in obesity. Weight Watchers, now an Ozempic prescriber, shifted from personal accountability due to Ozempic's superior business model.